NEW YORK (GenomeWeb) – Diagnostics development firm Eutropics today announced the signing of a $1.5 million contract with the National Cancer Institute to develop the Praedicare Dx platform for guiding treatment of acute myeloid leukemia patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.